Screening of ABO, Rh typing and unexpected alloantibodies in pregnant women attending antenatal care at Sriphat Medical Center, Faculty of Medicine, Chiang Mai University
Article Sidebar
Main Article Content
Abstract
Introduction: Pregnancy can stimulate a mother’s immune response to produce antibody to blood group antigens of fetal RBCs. Fetal RBCs with different blood group entering maternal blood circulation during pregnancy may stimulate maternal immune response. Maternal IgG anti-fetal RBCs can cross placenta to sensitize and destroy fetal RBCs causing hemolytic disease of the fetus and newborn (HDFN). Presently, screening of ABO, Rh typing and unexpected alloantibodies in pregnant women are routine tests for antenatal women. Therefore, the researchers were interested in studying the frequency of unexpected alloantibodies in pregnant women attending antenatal care at Sriphat Medical Center, Faculty of Medicine, Chiang Mai University.
Objectives: To determine the frequency of ABO, Rh typing and unexpected alloantibodies in pregnant women attending antenatal care of Sriphat Medical Center, Faculty of Medicine, Chiang Mai University.
Materials and methods: A total of 300 pregnant women attending antenatal care were tested for ABO, Rh typing and antibody screening. Antibody identification and autoantibody were performed on positive screening results.
Results: ABO phenotyping revealed blood group O, B, A, and AB were 50%, 28%, 18.67%, and 3.33%, respectively. All samples were Rh positive. Positive antibody screening of anti-Lea and anti-Leb were found in two samples. Both were not autoantibody. These two antibodies showed 2+ agglutination at room temperature, 37 oC and anti-human globulin phases as were found in antibody screening.
Conclusion: Anti-Lewis antibodies of both IgG and IgM were detected in this study. The IgG form may cause HDFN. Screening of alloantibodies in pregnant women, thus be helpful in monitoring one who is at risk of HDFN. Moreover, it is helpful for doctor to diagnose and plan for supportive care of HDFN.
Journal of Associated Medical Sciences 2017; 50(2): 153-158. Doi: 10.14456/jams.2017.18
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Personal views expressed by the contributors in their articles are not necessarily those of the Journal of Associated Medical Sciences, Faculty of Associated Medical Sciences, Chiang Mai University.
References
2. Dean L. Chapter 4 - Hemolytic disease of the new born. Blood groups and red cell antigens. National center for biotechnology information (US); 2005. [cited 2015 Sep 4]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK2266/pdf/Bookshelf_NBK2266.pdf.
3. de Haas M, Thurik FF, Koelewijn JM, van der Schoolt CE. Haemolytic disease of the fetus and newborn. Vox Sang 2015; 109: 99-113. doi: 10.1111/vox.12265. Epub 2015 Apr 20.
4. Stevenson DK, Vreman HJ, Wong RJ. Bilirubin production and the risk of bilirubin neurotoxicity. Semin perinatol 2011; 35: 121-6. doi: 10.1053/j.semperi.2011.02.005.
5. Doyle B, Quigley J, Lambert M, Crumlish J, Walsh C, McParland P, et al. A correlation between severity haemolytic disease of the fetus and newborn and maternal ABO blood group. Transfus Med 2014; 24: 239-43. doi: 10.1111/tme.12132. Epub 2014 Jun 28.
6. Sinkitjasub A, Surakamolert V, Chanta P. The prevalence of unexpected antibodies in pregnant women attending antenatal care (ANC) of Taksin hospital. J Hematol Transfus Med 2011; 21: 153-8.
7. Karim F, Moiz B, Kamran N. Risk of maternal alloimmunization in Southern Pakistan-study in a cohort of 1000 pregnant woman. Transfus Apher Sci 2015; 52: 99-102. doi: 10.1016/j.transci.2014.12.002. Epub 2014 Dec 11.
8. Mo Z, Li H, Huang L, Jiao W. Prevalence and specificity of RBC alloantibodies in the general hospitalized population in Guangxi. Transfus Med 2015; 25: 313-9. doi: 10.1111/tme.12222. Epub 2015 Jul 1.
9. Pal M, Williams B. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia. Pathology 2015; 47: 151-5. doi: 10.1097/PAT.0000000000000225.
10. Samung A, Bejrachandra S, Nathalang O, Plubjui P, Permpikul P. The detection of IgG maternal alloantibodies for safety transfusion in newborn at Siriraj hospital. J Hematol Transfus Med 2011; 21: 5-13.
11. Leelanuntawong T, Samung A. Hemolytic disease of the fetus and newborn. J prapokklao Hosp Clin Med Educat Center 2011; 28: 243-52.
12. Sanjum R, Kluabwang P, Wongsena W. Detection of IgG maternal alloantibodies causing jaundice of the newborn in Maesort hospital. Naresuan University Journal: Science and Technology 2014; 22: 22-39.
13. Sainio S, Nupponen I, Kuosmanen M, Aitokallio-Tallberg A, Ekholm E, Halmesmäki E, et al. Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study. Acta Obstet Gynecol Scand 2015; 94: 383-90. doi: 10.1111/aogs.12590. Epub 2015 Feb 11.
14. Nathalang O, Kuvanont S, Punyaprasiddhi P, et al. A preliminary study of the distribution of blood group systems in Thai blood donors determined by the gel test. Southeast Asian J Trop Med Public Health 2001; 32: 204-7.
15. Spitalnik S, Cowles J, Cox MT, Blumberg N. Detection of IgG anti-Lewis (a) antibodies in cord sera by kinetic Elisa. Vox Sang 1985; 48: 235-8.
16. Carreras Vescio LA, Torres OW, Virgilio OS, Pizzolato M. Mild hemolytic disease of the newborn due to anti-Lewis(a). Vox Sang 1993; 64: 194-5.
17. Bharucha ZS, Joshi SR, Bhatia HM. Hemolytic disease of the newborn due to anti-Le. Vox Sang 1981; 41: 36-9.
18. Samung A, Bejrachandra S, Nathalang O, Plubjui P, Permpikul P. The detection of IgG maternal alloantibodies for safety transfusion in newborn at Siriraj hospital. J Hematol Transfus Med 2011; 21: 5-13.
19. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol. 2012;2012:985646. doi: 10.1155/2012/985646. Epub 2011 Oct 1.